PALO ALTO (June 4, 2021)—Perkins Coie is pleased to have represented Synchron, a brain interface platform company, in its Series B $40 million round of financing led by Silicon Valley venture capital fund Khosla Ventures.

The funding will be used to launch a pivotal clinical study in the U.S. of Synchron’s StentrodeTM technology to enable the use of digital devices by patients with limb paralysis. Funds will also be used to seed a development pipeline of neurointerventional sensing and stimulating products addressing multiple neurological indications.

The Perkins Coie deal team was led by Palo Alto partner Adrian Rich and included associates Jessica North and Navneet Mattu. 

Perkins Coie is a leading international law firm that is known for providing high-value, strategic solutions and extraordinary client service on matters vital to our clients’ success. With more than 1,200 lawyers in offices across the United States and Asia, we provide a full array of corporate, commercial litigation, intellectual property, and regulatory legal advice to a broad range of clients, including many of the world’s most innovative companies and industry leaders as well as public and not-for-profit organizations.

Media Inquiries: Please email Justin Cole, Head of Media Relations.